Focus and Scope
Medical Journal of Indonesia is a peer-reviewed and open access journal that focuses on promoting medical sciences generated from basic sciences, clinical, and community or public health research to integrate researches in all aspects of human health. This journal publishes original articles, reviews, and also interesting case reports. Brief communications containing short features of medicine, latest developments in diagnostic procedures, treatment, or other health issues that is important for the development of health care system are also acceptable. Correspondence articles of our own published article are welcome.
Subjects suitable for publication include, but are not limited to the following fields of:
- Allergy and immunology
- Cancer and stem cells
- Cell and molecular biology
- Child health
- Internal medicine
- Neuro-psychiatric medicine
- Oral medicine
- Physical medicine and rehabilitation
- Surgery including orthopedic and urology
- Women's health
Medical Journal of Indonesia publishes peer-reviewed articles in basic medical research, clinical research, community research, case report/series, review article, and brief communication. All of the manuscripts must be submitted through online submission and go through peer review process as mentioned in another section. This journal also has other sections such as, editorial, correspondence, and commentary which are not peer-reviewed.
The submitted manuscript will be checked by an editor for its suitability with Medical Journal of Indonesias focus and scope and for major methodological flaws within two weeks. Staff will work with the author to fulfill all the requirements within two weeks. Every submitted manuscript which passes this step will then be checked for plagiarism by Similarity Check. The manuscript needs to be re-worked if indicated for minor plagiarism and will be rejected if indicated for major plagiarism. Then, an editor-in-charge and an editorial assistant will be assigned for the manuscript. In this stage, the manuscript will be assessed based on novelty and adherence to reporting guidelines. Subsequently, the manuscript will go through peer-review process. The revisions may be required and will be re-evaluated by the editor-in-charge after the authors providing sufficient responses. The manuscript will be passed to the editor-in-chief for any further revision and ultimately will take an editorial decision. The accepted manuscript will be sent to copyediting stage for correction of grammar and spelling errors, standardizing the journal in-house style, improving table, figure, and writing quality. The incomplete revision of this stage will result in pending scheduled publication. Then, the manuscript will enter production stage for typesetting. A pdf file is sent to the author for review and there should be no more scientific revision. A failure to comply will result in a delay of the publication since it needs editor confirmation for the changes. It will be scheduled for publication after the payment has been received. The final approval is needed from the corresponding author before it is published. The manuscript submitted by one of the editorial team of the Medical Journal of Indonesia will be processed by other editorial board members who do not have any conflict of interest with the manuscript and follow the same editorial process. [Indonesian version]
Peer Review Process
All submitted manuscripts (except editorial, commentary, and correspondence) in Medical Journal of Indonesia undergo double-blind peer review by at least two reviewers. All manuscripts are sent to the reviewers anonymously. Reviewers' comments are also sent anonymously to the corresponding author to take the necessary actions and responses. All the reviewers are subjected to submit their evaluation not more than six weeks. Medical Journal of Indonesia staff ensures that the referee reports are complete. On some occasions, the review process needs more time to seek the appropriate reviewers.
Authors retain copyright and grant the Faculty of Medicine Universitas Indonesia rights to publish the work licensed under a Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the works authorship and initial publication in Medical Journal of Indonesia. Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.
The commercial use of any article is not permitted without our prior written consent and payment of the appropriate fees, even if you are the author or the employer, funder or affiliate organization of the author of the article. For the purposes of these terms, commercial use means use in any manner that is primarily intended for or directed toward commercial advantage or monetary compensation, including but not limited to provision or distribution of any article or part of any article (including any abstract, figures or tables) in any format: to support marketing activities; in response to medical information requests; to support activities at a conference, exhibition or trade show; as resource material on a company or product-specific website. You may contact to our office at firstname.lastname@example.org.
The Medical Journal of Indonesia was founded in 1991 as the Medical Journal of the University of Indonesia. Since the first issue in 1992, it has been published quarterly, consistently, and continuously, covering a wide range of medical subjects and issues from every medical specialist aspect. In 1995, the name was changed to Medical Journal of Indonesia which reflected the widening of its coverage beyond Universitas Indonesia. The mission of our journal is to provide biomedical scientists, clinical, and public health researchers as well as other health care professionals with the media to publish their research works. Starting from 2011, Deutsch-Indonesische Gesellschaft für Medizin (DIGM) Medical Journal has been merged into the Medical Journal of Indonesia. This also means that DIGM is officially collaborating with the Medical Journal of Indonesia and Faculty of Medicine Universitas Indonesia as the owner and the publisher. The mission of the Medical Journal of Indonesia is to improve health care management by providing high-quality articles from Indonesia and worldwide.
This journal is published quarterly.
Open Access Policy
Medical Journal of Indonesia is an open access journal which provides immediate, worldwide, barrier-free access to the full text of all published articles without charge readers or their institutions for access. Readers have right to read, download, copy, distribute, print, search, or link to the full texts of all articles in the Medical Journal of Indonesia.
A preprint refers to the author’s version of a research manuscript shared publicly on an online preprint platform before undergoing a formal peer-review process in a journal. Medical Journal of Indonesia allows the submission of preprint manuscripts with prior notice in the cover letter by providing a link to the preprint and a description of any revisions or changes made in the submitted manuscript. Preprints will not be regarded as prior publications and will not adversely affect the review process.
Editorial materials will not be influenced by advertisement. Readers can criticize the advertisement by sending it to the office. Advertisement will appear in the print or online version depending on request. For all inquiries, contact the Medical Journal of Indonesia editorial office at Medical Journal of Indonesia, Education Tower 6th floor, IMERI building, Faculty of Medicine Universitas Indonesia, Jalan Salemba Raya 6, Jakarta, 10430, Indonesia; tel. +622129189160 ext201605; e-mail email@example.com.
The price per volume (four printed issues): international USD 160 (surface postage included), for ASEAN countries USD 100 (surface postage included), for Indonesia IDR 400,000 (surface postage excluded). The subscribers need to fill the forms ( Indonesian or foreign countries).
Medical Journal of Indonesia accepts revenues from various sources to ensure the quality of the peer-review process and published articles. The sources of income include publication fees, advertisement, events (training), subscription fees, and support from Faculty of Medicine Universitas Indonesia. None of the editorial decision is influenced by the revenue itself. The waived publication fee is covered by the Medical Journal of Indonesia to help researchers with limited resources. The waiving cost does not influence the editorial decision.
Updated - August 4th, 2023